Down-regulation of Bmi-1 inhibited the proliferation and increased the chemosensitivity of MCF-7 cells, indicating that Bmi-1 can be developed into a therapeutic option for the treatment of breast cancer. The gene discussed is BMI1; the disease is breast carcinoma.